Pharmaceuticals

Dupixent Proven Effective in Treating Chronic Obstructive Pulmonary Disease and Asthma

bexib
By bexib 0 Min Read

Results from the Phase 3 BOREAS and NOTUS trials showed that Dupixent reduced moderate to severe COPD exacerbations by 31% over 52 weeks.

You Might Also Like

Potential MS ‘game changer’ may also make you safer against viruses

Celebrating the 2024 PharmaTimes MSEA and NIEA Award Winners

US Pharma and Biotech Summit 2024: Solving drug pricing

Cencora’s VP of Emerging Therapies talks about innovative order-to-cash solutions for cell and gene therapy

AI Pulse Check

Share This Article
Previous Article 2:00PM Water Cooler 8/26/2024 | naked capitalism
Next Article Lifetime Show Spotlights Military Veterans Finding New Careers at U.S. Steel
Leave a Comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Stay Connected

Latest News

Upcoming seller boom for TikTok shops
Retail & E-commerce
The countdown to the reopening of the iconic Delano Miami Beach begins
Hospitality & Tourism
Remembering Maker Faires in 2024?
Manufacturing
Top 5 Open Banking Stories of 2024
Banking